| Performance | Chiffre d’affaires | Résultat | Trésorerie |
|---|---|---|---|
| NANOBIOTIX (2024) | 6,85M | -61,2M | 48,1M |
| ONWARD THERAPEUTICS FRANCE (2024) | 4,71M | 668K | 588K |
| ALAIN ONCOLOGIE CONSULTING (2021) | 499K | 101K | 230K |
| PHARMAENGINE EUROPE (2019) | 220K | 11,8K | 44,9K |
| AD BIO CONSULTING (2021) | 59,9K | 8,06K | 52,6K |
| EMERCELL (2020) | 1,2K | -142K | 99,4K |
| GUSTAVE ROUSSY TRANSFERT (2024) | 0 | 449K | 1,34M |